Literature DB >> 23996496

Frequent red cell transfusions reduced vascular endothelial activation and thrombogenicity in children with sickle cell anemia and high stroke risk.

Hyacinth I Hyacinth1, Robert J Adams, Jenifer H Voeks, Jacqueline M Hibbert, Beatrice E Gee.   

Abstract

Stroke is one of the most disabling complications of sickle cell anemia (SCA). The molecular mechanisms leading to stroke in SCA or by which packed red blood cell (PRBC) transfusion prevents strokes are not understood. We investigated the effects of PRBC transfusion on serum biomarkers in children with SCA who were at high-risk for stroke. Serum samples from 80 subjects were analyzed, including baseline, study exit time point and 1 year after study exit. Forty of the 80 samples were from subjects randomized to standard care and 40 from transfusion arm. Samples were assayed for levels of BDNF, sVCAM-1, sICAM-1, MPO, Cathepsin-D, PDGF-AA, PDGF-AB/BB, RANTES (CCL5), tPAI-1, and NCAM-1 using antibody immobilized bead assay. Significantly lower mean serum levels of sVCAM-1 (2.2 × 10(6) ± 0.8 × 10(6) pg/mL vs. 3.1 × 10(6) ± 0.9 × 10(6) pg/mL, P < 0.0001), Cathepsin-D (0.5 × 10(6) ± 0.1 × 10(6) pg/mL vs. 0.7 × 10(6) ± 0.2 × 10(6) pg/mL, P < 0.0001), PDGF-AA (10556 ± 4033 pg/mL vs. 14173 ± 4631 pg/mL, P = 0.0008), RANTES (0.1 × 10(6) ± 0.07 × 10(6) pg/mL vs. 0.2 × 10(6) ± 0.06 × 10(6) pg/mL, P < 0.006), and NCAM-1 (0.7 × 10(6) ± 0.2 × 10(6) pg/mL vs. 0.8 × 10(6) ± 0.1 × 10(6) pg/mL, P < 0.0006) were observed among participants who received PRBC transfusion, compared to those who received standard care. Twenty or more PRBC transfusion over 4 years was associated with lower serum levels of sVCAM-1 (P < 0.001), PDGF-AA (P = 0.025), and RANTES (P = 0.048). Low baseline level of BDNF (P = 0.025), sVCAM-1 (P = 0.025), PDGF-AA (P = 0.01), t-PAI-1 (P = 0.025) and sICAM-1 (P = 0.022) was associated with higher probability of stroke free survival. Beyond improving hemoglobin levels, our results suggest that the protective effects of PRBC transfusion on reducing stroke in SCD may result from reduced thrombogenesis and vascular remodeling.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23996496      PMCID: PMC4070426          DOI: 10.1002/ajh.23586

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  33 in total

1.  Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease.

Authors:  Jacqueline M Hibbert; Lewis L Hsu; Sam J Bhathena; Ikovwa Irune; Bismark Sarfo; Melissa S Creary; Beatrice E Gee; Ali I Mohamed; Iris D Buchanan; Ahmad Al-Mahmoud; Jonathan K Stiles
Journal:  Exp Biol Med (Maywood)       Date:  2005-01

2.  Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).

Authors:  Russell E Ware; Ronald W Helms
Journal:  Blood       Date:  2012-02-07       Impact factor: 22.113

3.  Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.

Authors:  Janet L Kwiatkowski; Alan R Cohen; Julian Garro; Ofelia Alvarez; Ramamorrthy Nagasubramanian; Sharada Sarnaik; Alexis Thompson; Gerald M Woods; William Schultz; Nicole Mortier; Peter Lane; Brigitta Mueller; Nancy Yovetich; Russell E Ware
Journal:  Am J Hematol       Date:  2011-11-25       Impact factor: 10.047

4.  Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease.

Authors:  Robert J Adams; Donald Brambilla
Journal:  N Engl J Med       Date:  2005-12-29       Impact factor: 91.245

5.  Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease.

Authors:  Monica L Hulbert; Robert C McKinstry; JoAnne L Lacey; Christopher J Moran; Julie A Panepinto; Alexis A Thompson; Sharada A Sarnaik; Gerald M Woods; James F Casella; Baba Inusa; Jo Howard; Fenella J Kirkham; Kofi A Anie; Jonathan E Mullin; Rebecca Ichord; Michael Noetzel; Yan Yan; Mark Rodeghier; Michael R Debaun
Journal:  Blood       Date:  2010-10-12       Impact factor: 22.113

6.  Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia.

Authors:  Monica L Hulbert; Douglas J Scothorn; Julie A Panepinto; J Paul Scott; George R Buchanan; Sharada Sarnaik; Robert Fallon; Jen-Yih Chu; Winfred Wang; James F Casella; Linda Resar; Brian Berman; Thomas Adamkiewicz; Lewis L Hsu; Kimberly Smith-Whitley; Donald Mahoney; Gerald Woods; Masayo Watanabe; Michael R DeBaun
Journal:  J Pediatr       Date:  2006-11       Impact factor: 4.406

7.  Plasma interleukin-1beta concentration is associated with stroke in sickle cell disease.

Authors:  Kwaku Asare; Beatrice E Gee; Jonathan K Stiles; Nana O Wilson; Adel Driss; Alexander Quarshie; Robert J Adams; Abdullah Kutlar; Jacqueline M Hibbert
Journal:  Cytokine       Date:  2009-11-08       Impact factor: 3.861

8.  Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions.

Authors:  Gregory J Kato; Robert P Hebbel; Martin H Steinberg; Mark T Gladwin
Journal:  Am J Hematol       Date:  2009-09       Impact factor: 10.047

9.  MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D.

Authors:  P Briozzo; J Badet; F Capony; I Pieri; P Montcourrier; D Barritault; H Rochefort
Journal:  Exp Cell Res       Date:  1991-06       Impact factor: 3.905

10.  Hemodynamic etiology of elevated flow velocity and stroke in sickle-cell disease.

Authors:  Isak Prohovnik; Anne Hurlet-Jensen; Robert Adams; Darryl De Vivo; Steven G Pavlakis
Journal:  J Cereb Blood Flow Metab       Date:  2009-02-11       Impact factor: 6.200

View more
  10 in total

1.  Contribution of Sickle Cell Disease to the Pediatric Stroke Burden Among Hospital Discharges of African-Americans-United States, 1997-2012.

Authors:  Charlotte Baker; Althea M Grant; Mary G George; Scott D Grosse; Thomas V Adamkiewicz
Journal:  Pediatr Blood Cancer       Date:  2015-07-14       Impact factor: 3.167

Review 2.  Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease.

Authors:  Eboni I Lance; James F Casella; Allen D Everett; Emily Barron-Casella
Journal:  Proteomics Clin Appl       Date:  2014-11-06       Impact factor: 3.494

3.  Brain-derived neurotrophic factor levels in pediatric sickle cell disease.

Authors:  Eboni I Lance; Emily Barron-Casella; Allen D Everett; James F Casella
Journal:  Pediatr Blood Cancer       Date:  2019-11-17       Impact factor: 3.167

4.  Red Cell Alloimmunization and Autoimmunization Among Sickle Cell Disease and Thalassemia Patients in Jazan Province, Saudi Arabia.

Authors:  Amr J Halawani; Abdullah A Mobarki; Ali H Arjan; Muhammad Saboor; Hassan A Hamali; Gasim Dobie; Khalaf F Alsharif
Journal:  Int J Gen Med       Date:  2022-04-15

5.  Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.

Authors:  Lise J Estcourt; Ruchika Kohli; Sally Hopewell; Marialena Trivella; Winfred C Wang
Journal:  Cochrane Database Syst Rev       Date:  2020-07-27

6.  Angiogenesis-Related Genes in Endothelial Progenitor Cells May Be Involved in Sickle Cell Stroke.

Authors:  Mirta T Ito; Sueli M da Silva Costa; Letícia C Baptista; Gabriela Q Carvalho-Siqueira; Dulcinéia M Albuquerque; Vinicius M Rios; Stephanie Ospina-Prieto; Roberta C Saez; Karla P Vieira; Fernando Cendes; Margareth C Ozelo; Sara Teresinha O Saad; Fernando F Costa; Mônica B Melo
Journal:  J Am Heart Assoc       Date:  2020-02-03       Impact factor: 5.501

7.  Elevated neuregulin-1β levels correlate with plasma biomarkers of cerebral injury and high stroke risk in children with sickle cell anemia.

Authors:  Christopher Chambliss; Tatayana Richardson; John Onyekaba; Juan Cespedes; Annette Nti; Keri Oxendine Harp; Iris Buchanan-Perry; Jonathan K Stiles; Beatrice E Gee
Journal:  Endocr Metab Sci       Date:  2021-02-14

8.  Biomarkers of clinical severity in treated and untreated sickle cell disease: a comparison by genotypes of a single center cohort and African Americans in the NHANES study.

Authors:  Franklin Njoku; Xu Zhang; Binal N Shah; Roberto F Machado; Jin Han; Santosh L Saraf; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2021-07-15       Impact factor: 8.615

9.  Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke.

Authors:  Hyacinth I Hyacinth; Robert J Adams; Charles S Greenberg; Jenifer H Voeks; Allyson Hill; Jacqueline M Hibbert; Beatrice E Gee
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

10.  Spectral domain optical coherence tomography findings in Turkish sickle-cell disease and beta thalassemia major patients.

Authors:  Mahmut Oğuz Ulusoy; Hakan Türk; Sertaç Argun Kıvanç
Journal:  J Curr Ophthalmol       Date:  2019-02-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.